Interstitial IgG antibody pharmacokinetics assessed by combined in vivo- and physiologically-based pharmacokinetic modelling approaches.

about

Advance in physiologically based pharmacokinetic modelling: from the organ level to suborgan level based on experimental data.

P2860

Q47755661-657F88EC-E22D-4C02-97A7-D980D86AEF5B

P2860

Interstitial IgG antibody pharmacokinetics assessed by combined in vivo- and physiologically-based pharmacokinetic modelling approaches.

Item

http://www.wikidata.org/entity/Q47901965

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Interstitial IgG antibody phar ...... okinetic modelling approaches.

@en

Interstitial IgG antibody phar ...... okinetic modelling approaches.

@nl

type

Item

label

Interstitial IgG antibody phar ...... okinetic modelling approaches.

@en

Interstitial IgG antibody phar ...... okinetic modelling approaches.

@nl

prefLabel

Interstitial IgG antibody phar ...... okinetic modelling approaches.

@en

Interstitial IgG antibody phar ...... okinetic modelling approaches.

@nl

P1476

Interstitial IgG antibody phar ...... cokinetic modelling approaches

@en

P2093

Ben-Fillippo Krippendorff

http://www.w3.org/2001/XMLSchema#string

Ludivine Fronton

http://www.w3.org/2001/XMLSchema#string

Michael B Otteneder

http://www.w3.org/2001/XMLSchema#string

Olav Tenstad

http://www.w3.org/2001/XMLSchema#string

Tine V Karlsen

http://www.w3.org/2001/XMLSchema#string

P2860

Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer

Microvascular permeability.

Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: what have we learned?

Interstitial-lymphatic mechanisms in the control of extracellular fluid volume.

Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability

Antibody pharmacokinetics and pharmacodynamics.

Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis.

Dose selection based on physiologically based pharmacokinetic (PBPK) approaches.

Clinical assessment of human lymph flow using removal rate constants of interstitial macromolecules: a critical review of lymphoscintigraphy.

Tissue concentrations: do we ever learn?

P304

7311-7330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1113/JP274819

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

595

http://www.w3.org/2001/XMLSchema#string

P50

Helge Wiig

Miro J Eigenmann

P577

2017-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28960303

http://www.w3.org/2001/XMLSchema#string

P932

5730850

http://www.w3.org/2001/XMLSchema#string

Interstitial IgG antibody pharmacokinetics assessed by combined in vivo- and physiologically-based pharmacokinetic modelling approaches.

about

P2860

P2860

Interstitial IgG antibody pharmacokinetics assessed by combined in vivo- and physiologically-based pharmacokinetic modelling approaches.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932